The Norwegian Medicines Agency states that a connection between blood clots and the AstraZeneca vaccine cannot be ruled out and that it must be closely monitored.
On Thursday, the European Medicines Agency (EMA) gave the green light to the AstraZeneca vaccine’s continued use.
“This means that the vaccine will continue to have conditional approval. However, this does not mean that it should or must be used in Norway,” director Audun Hågå in the Norwegian Medicines Agency noted.
He says that the Norwegian Medicines Agency can not yet rule out a connection between the vaccine and severe blood clots.
Norwegian researchers at Rikshospitalet believe there is such a connection.
NMA: Two people dead after receiving the AstraZeneca vaccine
The Norwegian Medicines Agency also confirmed that six people had serious complications after being vaccinated with AstraZeneca and that two of them have died.
“We have received reports of six cases,” (note: serious complications) director Audun Hågå in the Norwegian Medicines Agency said.
The second death that occurred after vaccination, and which is now being investigated, occurred at Tynset.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "Norwegian Medicines Agency: We cannot rule out a connection between blood clots and the AstraZeneca vaccine"